<DOC>
	<DOCNO>NCT00379223</DOCNO>
	<brief_summary>Natural evolution severe central retinal vein occlusion low visual acuity poor . A randomized clinical trial compare troxerutin platelet anti-aggregating agent ( drug treatment ) versus surgery drug treatment . Surgery include vitrectomy radial optic neurotomy . The primary outcome vision measure 6 month surgery .</brief_summary>
	<brief_title>Radial Optic Neurotomy Central Retinal Vein Occlusion : Randomized Trial</brief_title>
	<detailed_description>Central Retinal Vein Occlusion ( CRVO ) second frequently retinal vascular disease cause loss vision , diabetic retinopathy . No treatment CRVO clearly demonstrate beneficial long last visual result . Commonly use treatment option platelet anti-aggregating agent , correct rheologic factor troxerutin isovolumic hemodilution . Surgical treatment CRVO recently propose ( 2001 ) study numerous non comparative pilot study . Limited encouraging result motivate randomise controlled trial . We evaluate 6 month visual acuity surgery associate par plana vitrectomy radial optic neurotomy , patient central vein occlusion bad vision , associate correction rheologic factor .</detailed_description>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<criteria>Central Retinal Vein Occlusion oedematous hemorrhagic ( fundus exam fluorescein angiography ) Visual Acuity ( VA ) ≤ 20/200 ETDRS chart Decreased VA since 1 month , less 3 month Common care recommendation CRVO period recruitment ( Control ocular pressure associate hypertension glaucoma ; Hemodilution hematocrit ≥ 38 % , cardiovascular contraindication , maintain hematocrit 38 % 6 week ; Troxerutin ( 3 /d ) aspirin ( 100 160 mg/d ) ; Clinical angiographic control look retinal ischemia indicate laser PRP prevent neovascular glaucoma . Signed informed consent . Ischemic CRVO : 1 More 30 disc diameter ischemia fluorescein angiography and/or •2 If Angiogram uninterpretable hemorrhage , deficit afferent pupillary reflex 0.9 photographic filter ( propose Hayreh ) indication laser PRP laser PRP already do , Rubeosis neovascular glaucoma , Bilateral diabetic retinopathy preproliferative proliferative , Uncharacterized coagulation disease , anticoagulant treatment , Untreated systemic disease ( diabetes , severe high blood pressure , Cardiac failure ) ou eye disease ( glaucoma ) , Contraindication document allergy troxerutin platelet antiaggregating agent , Contraindication surgical procedure incapacity receive informed consent , incapacity follow study schedule</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>retinal vein occlusion</keyword>
	<keyword>vitrectomy</keyword>
	<keyword>surgery</keyword>
	<keyword>retinal disorder</keyword>
	<keyword>vascular disease</keyword>
</DOC>